

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | skeletal muscle contraction (GO:0003009) | 9.14085177 |
| 2 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 7.99678013 |
| 3 | actin filament-based movement (GO:0030048) | 7.72495610 |
| 4 | skeletal muscle adaptation (GO:0043501) | 7.30986850 |
| 5 | sarcomere organization (GO:0045214) | 7.02799104 |
| 6 | plasma membrane repair (GO:0001778) | 6.97702901 |
| 7 | skeletal muscle fiber development (GO:0048741) | 6.68381019 |
| 8 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.45220824 |
| 9 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.20638284 |
| 10 | myofibril assembly (GO:0030239) | 6.15502129 |
| 11 | striated muscle contraction (GO:0006941) | 6.14611034 |
| 12 | myotube cell development (GO:0014904) | 5.93331438 |
| 13 | muscle contraction (GO:0006936) | 5.44585923 |
| 14 | skeletal muscle tissue regeneration (GO:0043403) | 5.33915451 |
| 15 | response to inactivity (GO:0014854) | 5.33535101 |
| 16 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.29242259 |
| 17 | actomyosin structure organization (GO:0031032) | 5.28103031 |
| 18 | striated muscle atrophy (GO:0014891) | 5.21731477 |
| 19 | muscle system process (GO:0003012) | 4.93728874 |
| 20 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.91186810 |
| 21 | cardiac myofibril assembly (GO:0055003) | 4.90677666 |
| 22 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.88426452 |
| 23 | striated muscle adaptation (GO:0014888) | 4.80842715 |
| 24 | muscle fiber development (GO:0048747) | 4.74189716 |
| 25 | carnitine shuttle (GO:0006853) | 4.57250902 |
| 26 | muscle atrophy (GO:0014889) | 4.52539728 |
| 27 | response to muscle activity (GO:0014850) | 4.51169491 |
| 28 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.40181964 |
| 29 | muscle cell fate commitment (GO:0042693) | 4.39817933 |
| 30 | muscle cell cellular homeostasis (GO:0046716) | 4.37609216 |
| 31 | regulation of cell communication by electrical coupling (GO:0010649) | 4.36059340 |
| 32 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.35945541 |
| 33 | cardiac muscle contraction (GO:0060048) | 4.35470162 |
| 34 | cytidine metabolic process (GO:0046087) | 4.30343062 |
| 35 | cytidine catabolic process (GO:0006216) | 4.30343062 |
| 36 | cytidine deamination (GO:0009972) | 4.30343062 |
| 37 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.22540284 |
| 38 | glycogen catabolic process (GO:0005980) | 4.20799372 |
| 39 | creatine metabolic process (GO:0006600) | 4.13422319 |
| 40 | cardiac muscle cell development (GO:0055013) | 4.13185682 |
| 41 | adult heart development (GO:0007512) | 4.12264507 |
| 42 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.09822448 |
| 43 | striated muscle cell development (GO:0055002) | 4.04127653 |
| 44 | glycogen biosynthetic process (GO:0005978) | 3.96270298 |
| 45 | glucan biosynthetic process (GO:0009250) | 3.96270298 |
| 46 | cardiac cell development (GO:0055006) | 3.94763096 |
| 47 | positive regulation of myoblast differentiation (GO:0045663) | 3.93268520 |
| 48 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.92450548 |
| 49 | glucan catabolic process (GO:0009251) | 3.92391213 |
| 50 | muscle organ development (GO:0007517) | 3.87169380 |
| 51 | skeletal muscle tissue development (GO:0007519) | 3.86818665 |
| 52 | muscle adaptation (GO:0043500) | 3.86391058 |
| 53 | muscle structure development (GO:0061061) | 3.81741948 |
| 54 | fatty acid transmembrane transport (GO:1902001) | 3.79902997 |
| 55 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.75221390 |
| 56 | NADH metabolic process (GO:0006734) | 3.74673035 |
| 57 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.71827042 |
| 58 | muscle hypertrophy in response to stress (GO:0003299) | 3.71827042 |
| 59 | cardiac muscle adaptation (GO:0014887) | 3.71827042 |
| 60 | regulation of myoblast differentiation (GO:0045661) | 3.70698562 |
| 61 | regulation of relaxation of muscle (GO:1901077) | 3.70326752 |
| 62 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.68144280 |
| 63 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.68144280 |
| 64 | negative regulation of muscle hypertrophy (GO:0014741) | 3.67667157 |
| 65 | myoblast fusion (GO:0007520) | 3.66623838 |
| 66 | regulation of the force of heart contraction (GO:0002026) | 3.64573664 |
| 67 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.64258133 |
| 68 | cellular polysaccharide catabolic process (GO:0044247) | 3.62984049 |
| 69 | positive regulation of myotube differentiation (GO:0010831) | 3.61983269 |
| 70 | muscle tissue morphogenesis (GO:0060415) | 3.58734491 |
| 71 | regulation of striated muscle contraction (GO:0006942) | 3.58073668 |
| 72 | striated muscle hypertrophy (GO:0014897) | 3.56809986 |
| 73 | regulation of membrane repolarization (GO:0060306) | 3.55258161 |
| 74 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.55039430 |
| 75 | cardiac muscle hypertrophy (GO:0003300) | 3.51022854 |
| 76 | muscle cell development (GO:0055001) | 3.50957888 |
| 77 | regulation of actin filament-based movement (GO:1903115) | 3.50279298 |
| 78 | polysaccharide catabolic process (GO:0000272) | 3.46986258 |
| 79 | heart contraction (GO:0060047) | 3.46508917 |
| 80 | heart process (GO:0003015) | 3.46508917 |
| 81 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.44107684 |
| 82 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.44107684 |
| 83 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.43725073 |
| 84 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.43678591 |
| 85 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.42390758 |
| 86 | myotube differentiation (GO:0014902) | 3.39440794 |
| 87 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.38628824 |
| 88 | negative regulation of skeletal muscle tissue development (GO:0048642) | 3.37629905 |
| 89 | carnitine transmembrane transport (GO:1902603) | 3.35029382 |
| 90 | positive regulation of cation channel activity (GO:2001259) | 3.29864384 |
| 91 | 2-oxoglutarate metabolic process (GO:0006103) | 3.27634382 |
| 92 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.27378590 |
| 93 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.27102948 |
| 94 | relaxation of muscle (GO:0090075) | 3.27087458 |
| 95 | syncytium formation (GO:0006949) | 3.26301792 |
| 96 | muscle hypertrophy (GO:0014896) | 3.24819367 |
| 97 | response to activity (GO:0014823) | 3.24742165 |
| 98 | regulation of cardioblast proliferation (GO:0003264) | 3.23572680 |
| 99 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 3.23572680 |
| 100 | regulation of muscle contraction (GO:0006937) | 3.22383785 |
| 101 | glycogen metabolic process (GO:0005977) | 3.22119264 |
| 102 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 3.21422677 |
| 103 | negative regulation of heart growth (GO:0061117) | 3.21422677 |
| 104 | regulation of muscle system process (GO:0090257) | 3.20538726 |
| 105 | purine nucleotide salvage (GO:0032261) | 3.17145428 |
| 106 | glucan metabolic process (GO:0044042) | 3.15257503 |
| 107 | cellular glucan metabolic process (GO:0006073) | 3.15257503 |
| 108 | skeletal muscle cell differentiation (GO:0035914) | 3.15219072 |
| 109 | tricarboxylic acid cycle (GO:0006099) | 3.13287001 |
| 110 | muscle organ morphogenesis (GO:0048644) | 3.11351508 |
| 111 | regulation of myotube differentiation (GO:0010830) | 3.04783760 |
| 112 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.04735754 |
| 113 | muscle tissue development (GO:0060537) | 3.03933976 |
| 114 | negative regulation of protein localization to cell surface (GO:2000009) | 3.01111844 |
| 115 | striated muscle tissue development (GO:0014706) | 3.00788930 |
| 116 | regulation of sarcomere organization (GO:0060297) | 3.00058230 |
| 117 | amino-acid betaine transport (GO:0015838) | 2.99506169 |
| 118 | actin-myosin filament sliding (GO:0033275) | 12.1206668 |
| 119 | muscle filament sliding (GO:0030049) | 12.1206668 |
| 120 | regulation of skeletal muscle contraction (GO:0014819) | 11.0439054 |
| 121 | actin-mediated cell contraction (GO:0070252) | 10.2288466 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.57420840 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.48563585 |
| 3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.47125326 |
| 4 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.46181300 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.30755763 |
| 6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.11149199 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.11117247 |
| 8 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.82684591 |
| 9 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.79139476 |
| 10 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.64748278 |
| 11 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.48337699 |
| 12 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.48337699 |
| 13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.31403728 |
| 14 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.28063432 |
| 15 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.26845203 |
| 16 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.22855899 |
| 17 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.15412654 |
| 18 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.14497784 |
| 19 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.07939107 |
| 20 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.01701483 |
| 21 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.99713372 |
| 22 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.92913701 |
| 23 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.92401026 |
| 24 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.83475907 |
| 25 | CJUN_26792858_Chip-Seq_BT549_Human | 1.81256780 |
| 26 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.78030383 |
| 27 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.70478017 |
| 28 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.58018670 |
| 29 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.55492389 |
| 30 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.52375161 |
| 31 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.50392524 |
| 32 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.49157644 |
| 33 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.47611794 |
| 34 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.42386955 |
| 35 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.42284643 |
| 36 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.42281177 |
| 37 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.41896672 |
| 38 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.41176063 |
| 39 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.40720370 |
| 40 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.39513815 |
| 41 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.34050634 |
| 42 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.33957205 |
| 43 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.33431381 |
| 44 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.30910406 |
| 45 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.24891109 |
| 46 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.23779419 |
| 47 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.22927893 |
| 48 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.22634721 |
| 49 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.22216029 |
| 50 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.22120872 |
| 51 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.21655526 |
| 52 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.21262614 |
| 53 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.20606411 |
| 54 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.18673840 |
| 55 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.18258353 |
| 56 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.18206802 |
| 57 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.17383494 |
| 58 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.16653196 |
| 59 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.16639490 |
| 60 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.16629675 |
| 61 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.16230231 |
| 62 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.15166650 |
| 63 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.14745646 |
| 64 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.14002948 |
| 65 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.12029220 |
| 66 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.11797973 |
| 67 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.10992480 |
| 68 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.10793681 |
| 69 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.10793681 |
| 70 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.10623601 |
| 71 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.09991515 |
| 72 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.09972918 |
| 73 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.09765781 |
| 74 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.09651013 |
| 75 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.09515846 |
| 76 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.08823506 |
| 77 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.08523033 |
| 78 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.08078124 |
| 79 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.08078124 |
| 80 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.06963198 |
| 81 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.06185694 |
| 82 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.05592952 |
| 83 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.05432615 |
| 84 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.05334172 |
| 85 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.05216244 |
| 86 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.05085789 |
| 87 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.04371948 |
| 88 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.02008631 |
| 89 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.00844668 |
| 90 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.00089816 |
| 91 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.00089816 |
| 92 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.99820317 |
| 93 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.99725930 |
| 94 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.99310715 |
| 95 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.97662459 |
| 96 | VDR_22108803_ChIP-Seq_LS180_Human | 0.96977945 |
| 97 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96477882 |
| 98 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.96262291 |
| 99 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.95847899 |
| 100 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.95756670 |
| 101 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.95118893 |
| 102 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.95027591 |
| 103 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.94570105 |
| 104 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.94445809 |
| 105 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.93356663 |
| 106 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.93283733 |
| 107 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.93281042 |
| 108 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.93101453 |
| 109 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.92304943 |
| 110 | TP53_16413492_ChIP-PET_HCT116_Human | 0.92246048 |
| 111 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.91036940 |
| 112 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.90703341 |
| 113 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.90449153 |
| 114 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89980002 |
| 115 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.89943320 |
| 116 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89845802 |
| 117 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.89818849 |
| 118 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89156136 |
| 119 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.88729173 |
| 120 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.88537406 |
| 121 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88244018 |
| 122 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.88100385 |
| 123 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.87955353 |
| 124 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.87224452 |
| 125 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.87100509 |
| 126 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.86348031 |
| 127 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.86207988 |
| 128 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.86170308 |
| 129 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.86148917 |
| 130 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.86091486 |
| 131 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.85861013 |
| 132 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85789041 |
| 133 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.85292450 |
| 134 | * FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.85079599 |
| 135 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.84979705 |
| 136 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.84201800 |
| 137 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.83973773 |
| 138 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.83706052 |
| 139 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.83545806 |
| 140 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.83471840 |
| 141 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.83471840 |
| 142 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.83243785 |
| 143 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.82998808 |
| 144 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.81973319 |
| 145 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81161510 |
| 146 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.81009141 |
| 147 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.80098369 |
| 148 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79987159 |
| 149 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.79639080 |
| 150 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.78856843 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 6.21638157 |
| 2 | MP0000749_muscle_degeneration | 6.06320305 |
| 3 | MP0000751_myopathy | 5.51288573 |
| 4 | MP0003646_muscle_fatigue | 4.41545095 |
| 5 | MP0004036_abnormal_muscle_relaxation | 3.80034873 |
| 6 | MP0002106_abnormal_muscle_physiology | 3.75024451 |
| 7 | MP0000747_muscle_weakness | 3.64309739 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 3.57372216 |
| 9 | MP0004087_abnormal_muscle_fiber | 3.32205025 |
| 10 | MP0005369_muscle_phenotype | 3.28626843 |
| 11 | MP0000759_abnormal_skeletal_muscle | 3.26624351 |
| 12 | MP0000750_abnormal_muscle_regeneration | 3.26437201 |
| 13 | * MP0005620_abnormal_muscle_contractility | 3.13955048 |
| 14 | MP0002269_muscular_atrophy | 2.99176250 |
| 15 | MP0000733_abnormal_muscle_development | 2.62936712 |
| 16 | MP0004084_abnormal_cardiac_muscle | 2.59448927 |
| 17 | MP0005275_abnormal_skin_tensile | 2.55861771 |
| 18 | MP0008438_abnormal_cutaneous_collagen | 2.47245419 |
| 19 | MP0002108_abnormal_muscle_morphology | 2.47238275 |
| 20 | MP0005503_abnormal_tendon_morphology | 2.34666654 |
| 21 | MP0004130_abnormal_muscle_cell | 2.30828049 |
| 22 | MP0004233_abnormal_muscle_weight | 2.27588303 |
| 23 | * MP0005330_cardiomyopathy | 2.23762205 |
| 24 | MP0004215_abnormal_myocardial_fiber | 1.96781356 |
| 25 | * MP0002972_abnormal_cardiac_muscle | 1.79951863 |
| 26 | MP0000013_abnormal_adipose_tissue | 1.73950154 |
| 27 | MP0002332_abnormal_exercise_endurance | 1.72948288 |
| 28 | MP0003950_abnormal_plasma_membrane | 1.58788617 |
| 29 | MP0004484_altered_response_of | 1.54773729 |
| 30 | * MP0010630_abnormal_cardiac_muscle | 1.46852852 |
| 31 | MP0001544_abnormal_cardiovascular_syste | 1.30699090 |
| 32 | MP0005385_cardiovascular_system_phenoty | 1.30699090 |
| 33 | MP0001661_extended_life_span | 1.19173492 |
| 34 | MP0004185_abnormal_adipocyte_glucose | 1.18222376 |
| 35 | MP0004134_abnormal_chest_morphology | 1.17626663 |
| 36 | MP0000762_abnormal_tongue_morphology | 1.17370436 |
| 37 | MP0010030_abnormal_orbit_morphology | 1.13808839 |
| 38 | MP0006036_abnormal_mitochondrial_physio | 1.12358060 |
| 39 | MP0003705_abnormal_hypodermis_morpholog | 1.12290772 |
| 40 | MP0009250_abnormal_appendicular_skeleto | 1.12148814 |
| 41 | MP0003137_abnormal_impulse_conducting | 1.10363504 |
| 42 | MP0005666_abnormal_adipose_tissue | 1.08406234 |
| 43 | MP0006138_congestive_heart_failure | 1.07428043 |
| 44 | MP0002971_abnormal_brown_adipose | 1.06865261 |
| 45 | MP0002127_abnormal_cardiovascular_syste | 1.03554052 |
| 46 | MP0005367_renal/urinary_system_phenotyp | 1.02904420 |
| 47 | MP0000516_abnormal_urinary_system | 1.02904420 |
| 48 | MP0008775_abnormal_heart_ventricle | 1.01482196 |
| 49 | MP0003221_abnormal_cardiomyocyte_apopto | 0.99641017 |
| 50 | MP0005375_adipose_tissue_phenotype | 0.98779156 |
| 51 | MP0004272_abnormal_basement_membrane | 0.97744348 |
| 52 | MP0002234_abnormal_pharynx_morphology | 0.97649286 |
| 53 | MP0003566_abnormal_cell_adhesion | 0.94006767 |
| 54 | MP0003279_aneurysm | 0.92501925 |
| 55 | MP0003385_abnormal_body_wall | 0.92469916 |
| 56 | MP0003136_yellow_coat_color | 0.90198196 |
| 57 | MP0009780_abnormal_chondrocyte_physiolo | 0.88173573 |
| 58 | MP0000003_abnormal_adipose_tissue | 0.87833395 |
| 59 | MP0003941_abnormal_skin_development | 0.86977702 |
| 60 | MP0003828_pulmonary_edema | 0.83781778 |
| 61 | MP0002822_catalepsy | 0.80575489 |
| 62 | MP0001299_abnormal_eye_distance/ | 0.79296948 |
| 63 | MP0009384_cardiac_valve_regurgitation | 0.78420144 |
| 64 | MP0005670_abnormal_white_adipose | 0.77167325 |
| 65 | MP0010386_abnormal_urinary_bladder | 0.75752879 |
| 66 | MP0002060_abnormal_skin_morphology | 0.75662402 |
| 67 | MP0004270_analgesia | 0.75171576 |
| 68 | * MP0000266_abnormal_heart_morphology | 0.74485121 |
| 69 | MP0003567_abnormal_fetal_cardiomyocyte | 0.73379442 |
| 70 | MP0004085_abnormal_heartbeat | 0.71334616 |
| 71 | MP0005266_abnormal_metabolism | 0.70622558 |
| 72 | MP0001958_emphysema | 0.70431874 |
| 73 | MP0000343_altered_response_to | 0.67328818 |
| 74 | MP0004043_abnormal_pH_regulation | 0.65575430 |
| 75 | MP0010368_abnormal_lymphatic_system | 0.64223968 |
| 76 | MP0000534_abnormal_ureter_morphology | 0.62705131 |
| 77 | MP0004510_myositis | 0.59979153 |
| 78 | MP0000767_abnormal_smooth_muscle | 0.59134095 |
| 79 | MP0002254_reproductive_system_inflammat | 0.58822765 |
| 80 | MP0005508_abnormal_skeleton_morphology | 0.58744441 |
| 81 | MP0002638_abnormal_pupillary_reflex | 0.58362526 |
| 82 | MP0000230_abnormal_systemic_arterial | 0.54858627 |
| 83 | MP0002896_abnormal_bone_mineralization | 0.52903523 |
| 84 | MP0004142_abnormal_muscle_tone | 0.52494517 |
| 85 | MP0002114_abnormal_axial_skeleton | 0.51430749 |
| 86 | MP0004147_increased_porphyrin_level | 0.50864287 |
| 87 | MP0002249_abnormal_larynx_morphology | 0.50661004 |
| 88 | MP0005167_abnormal_blood-brain_barrier | 0.50363112 |
| 89 | MP0005171_absent_coat_pigmentation | 0.50239056 |
| 90 | MP0003045_fibrosis | 0.49711924 |
| 91 | MP0001879_abnormal_lymphatic_vessel | 0.49338316 |
| 92 | MP0005423_abnormal_somatic_nervous | 0.48310158 |
| 93 | MP0003879_abnormal_hair_cell | 0.47266654 |
| 94 | MP0003755_abnormal_palate_morphology | 0.46486432 |
| 95 | MP0005187_abnormal_penis_morphology | 0.45763195 |
| 96 | MP0000372_irregular_coat_pigmentation | 0.44879274 |
| 97 | MP0001243_abnormal_dermal_layer | 0.44084027 |
| 98 | MP0002796_impaired_skin_barrier | 0.43833560 |
| 99 | MP0005451_abnormal_body_composition | 0.43671263 |
| 100 | * MP0002128_abnormal_blood_circulation | 0.43384594 |
| 101 | MP0002734_abnormal_mechanical_nocicepti | 0.43252881 |
| 102 | MP0005165_increased_susceptibility_to | 0.42781360 |
| 103 | MP0001270_distended_abdomen | 0.42729290 |
| 104 | MP0002925_abnormal_cardiovascular_devel | 0.42431601 |
| 105 | MP0002932_abnormal_joint_morphology | 0.42103034 |
| 106 | MP0000049_abnormal_middle_ear | 0.42026416 |
| 107 | MP0008569_lethality_at_weaning | 0.40554740 |
| 108 | MP0000163_abnormal_cartilage_morphology | 0.40107982 |
| 109 | MP0000383_abnormal_hair_follicle | 0.38521271 |
| 110 | MP0002877_abnormal_melanocyte_morpholog | 0.38106471 |
| 111 | MP0003948_abnormal_gas_homeostasis | 0.36871955 |
| 112 | MP0001346_abnormal_lacrimal_gland | 0.36458678 |
| 113 | MP0002078_abnormal_glucose_homeostasis | 0.35968721 |
| 114 | MP0001849_ear_inflammation | 0.35778530 |
| 115 | MP0005623_abnormal_meninges_morphology | 0.35343650 |
| 116 | MP0006035_abnormal_mitochondrial_morpho | 0.33694951 |
| 117 | MP0005595_abnormal_vascular_smooth | 0.31987467 |
| 118 | MP0004858_abnormal_nervous_system | 0.31472855 |
| 119 | MP0005376_homeostasis/metabolism_phenot | 0.30957990 |
| 120 | MP0006276_abnormal_autonomic_nervous | 0.29846462 |
| 121 | MP0001943_abnormal_respiration | 0.27918165 |
| 122 | MP0005452_abnormal_adipose_tissue | 0.27311893 |
| 123 | MP0002876_abnormal_thyroid_physiology | 0.25728336 |
| 124 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.23500928 |
| 125 | MP0005332_abnormal_amino_acid | 0.22286547 |
| 126 | MP0002066_abnormal_motor_capabilities/c | 0.21667415 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 9.15516420 |
| 2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 8.99147935 |
| 3 | Nemaline bodies (HP:0003798) | 8.57499097 |
| 4 | Type 1 muscle fiber predominance (HP:0003803) | 7.88215906 |
| 5 | Exercise-induced myalgia (HP:0003738) | 7.25248291 |
| 6 | Distal arthrogryposis (HP:0005684) | 7.11102420 |
| 7 | Exercise-induced muscle cramps (HP:0003710) | 6.54098909 |
| 8 | Round ear (HP:0100830) | 6.13969346 |
| 9 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.95922567 |
| 10 | Myopathic facies (HP:0002058) | 5.94230939 |
| 11 | Ulnar deviation of the wrist (HP:0003049) | 5.68920715 |
| 12 | Calf muscle hypertrophy (HP:0008981) | 5.65441612 |
| 13 | Muscle fiber splitting (HP:0003555) | 5.21429634 |
| 14 | Hyporeflexia of lower limbs (HP:0002600) | 5.09729482 |
| 15 | Calcaneovalgus deformity (HP:0001848) | 5.08049575 |
| 16 | Deformed tarsal bones (HP:0008119) | 4.83238513 |
| 17 | Absent phalangeal crease (HP:0006109) | 4.61981760 |
| 18 | EMG: myopathic abnormalities (HP:0003458) | 4.55840040 |
| 19 | Abnormality of the calf musculature (HP:0001430) | 4.53501752 |
| 20 | Difficulty running (HP:0009046) | 4.51045411 |
| 21 | Increased connective tissue (HP:0009025) | 4.46815509 |
| 22 | Myoglobinuria (HP:0002913) | 4.01513281 |
| 23 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.87260171 |
| 24 | Abnormal finger flexion creases (HP:0006143) | 3.84592744 |
| 25 | Muscle stiffness (HP:0003552) | 3.71097217 |
| 26 | Neck muscle weakness (HP:0000467) | 3.70240742 |
| 27 | Malignant hyperthermia (HP:0002047) | 3.61778051 |
| 28 | Myotonia (HP:0002486) | 3.57585395 |
| 29 | Bundle branch block (HP:0011710) | 3.54858088 |
| 30 | Increased variability in muscle fiber diameter (HP:0003557) | 3.52142647 |
| 31 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.49062354 |
| 32 | Subaortic stenosis (HP:0001682) | 3.49062354 |
| 33 | Sudden death (HP:0001699) | 3.48332067 |
| 34 | Rhabdomyolysis (HP:0003201) | 3.41660326 |
| 35 | Abnormality of the calcaneus (HP:0008364) | 3.30191425 |
| 36 | Difficulty climbing stairs (HP:0003551) | 3.22544641 |
| 37 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.14186543 |
| 38 | Rimmed vacuoles (HP:0003805) | 3.10187984 |
| 39 | Fatigable weakness (HP:0003473) | 3.09677363 |
| 40 | Abnormality of the neuromuscular junction (HP:0003398) | 3.09677363 |
| 41 | Distal lower limb muscle weakness (HP:0009053) | 2.93820972 |
| 42 | Fetal akinesia sequence (HP:0001989) | 2.85892209 |
| 43 | Slender build (HP:0001533) | 2.83481499 |
| 44 | Frequent falls (HP:0002359) | 2.82080829 |
| 45 | Spinal rigidity (HP:0003306) | 2.79143436 |
| 46 | Areflexia of lower limbs (HP:0002522) | 2.78789148 |
| 47 | Facial diplegia (HP:0001349) | 2.76876255 |
| 48 | Right ventricular cardiomyopathy (HP:0011663) | 2.69569926 |
| 49 | Scapular winging (HP:0003691) | 2.67610743 |
| 50 | Bulbar palsy (HP:0001283) | 2.67342844 |
| 51 | Shoulder girdle muscle weakness (HP:0003547) | 2.60268555 |
| 52 | Gowers sign (HP:0003391) | 2.58851765 |
| 53 | Pelvic girdle muscle weakness (HP:0003749) | 2.58140846 |
| 54 | Asymmetric septal hypertrophy (HP:0001670) | 2.54763468 |
| 55 | Ventricular tachycardia (HP:0004756) | 2.49319089 |
| 56 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.49204861 |
| 57 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.49204861 |
| 58 | Weak cry (HP:0001612) | 2.48442626 |
| 59 | Generalized muscle weakness (HP:0003324) | 2.47896420 |
| 60 | EMG: neuropathic changes (HP:0003445) | 2.45653480 |
| 61 | Hyperkalemia (HP:0002153) | 2.42821956 |
| 62 | Tarsal synostosis (HP:0008368) | 2.34044084 |
| 63 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.33403752 |
| 64 | Hip contracture (HP:0003273) | 2.31625318 |
| 65 | Popliteal pterygium (HP:0009756) | 2.29797173 |
| 66 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.28468577 |
| 67 | Lipoatrophy (HP:0100578) | 2.26195045 |
| 68 | Muscular dystrophy (HP:0003560) | 2.22296331 |
| 69 | Heart block (HP:0012722) | 2.20029520 |
| 70 | Limb-girdle muscle atrophy (HP:0003797) | 2.19432431 |
| 71 | Limb-girdle muscle weakness (HP:0003325) | 2.15625520 |
| 72 | Synostosis involving bones of the lower limbs (HP:0009138) | 2.14104426 |
| 73 | Synostosis involving bones of the feet (HP:0009140) | 2.14104426 |
| 74 | Type 2 muscle fiber atrophy (HP:0003554) | 2.09400190 |
| 75 | Abnormal atrioventricular conduction (HP:0005150) | 2.07743990 |
| 76 | Proximal amyotrophy (HP:0007126) | 2.05574579 |
| 77 | Ulnar deviation of finger (HP:0009465) | 2.04204675 |
| 78 | Abnormality of the foot musculature (HP:0001436) | 2.02245057 |
| 79 | Aplasia of the musculature (HP:0100854) | 1.97891265 |
| 80 | Increased density of long bones (HP:0006392) | 1.97702995 |
| 81 | Distal lower limb amyotrophy (HP:0008944) | 1.97620715 |
| 82 | Aortic aneurysm (HP:0004942) | 1.96244852 |
| 83 | Dilated cardiomyopathy (HP:0001644) | 1.93968057 |
| 84 | Hypoplastic ischia (HP:0003175) | 1.91887646 |
| 85 | Metatarsus adductus (HP:0001840) | 1.91027105 |
| 86 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.87530621 |
| 87 | Progressive muscle weakness (HP:0003323) | 1.85776751 |
| 88 | Muscle fiber atrophy (HP:0100295) | 1.80718661 |
| 89 | Atrial fibrillation (HP:0005110) | 1.79447553 |
| 90 | Lower limb amyotrophy (HP:0007210) | 1.78567107 |
| 91 | Mesomelia (HP:0003027) | 1.77450396 |
| 92 | Nonprogressive disorder (HP:0003680) | 1.77051003 |
| 93 | Waddling gait (HP:0002515) | 1.72663093 |
| 94 | Limited hip movement (HP:0008800) | 1.69522590 |
| 95 | Aortic dissection (HP:0002647) | 1.69325158 |
| 96 | Abnormality of the ischium (HP:0003174) | 1.69119245 |
| 97 | Hypoplastic heart (HP:0001961) | 1.68078323 |
| 98 | Easy fatigability (HP:0003388) | 1.67994181 |
| 99 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.65740949 |
| 100 | Long clavicles (HP:0000890) | 1.63795690 |
| 101 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.63332270 |
| 102 | Steppage gait (HP:0003376) | 1.61425894 |
| 103 | Amniotic constriction ring (HP:0009775) | 1.60408706 |
| 104 | Abnormality of placental membranes (HP:0011409) | 1.60408706 |
| 105 | Primary atrial arrhythmia (HP:0001692) | 1.60172215 |
| 106 | Paralysis (HP:0003470) | 1.59906046 |
| 107 | Ventricular arrhythmia (HP:0004308) | 1.58808285 |
| 108 | Foot dorsiflexor weakness (HP:0009027) | 1.55008756 |
| 109 | Exercise intolerance (HP:0003546) | 1.53923902 |
| 110 | Supraventricular tachycardia (HP:0004755) | 1.53842378 |
| 111 | Wrist flexion contracture (HP:0001239) | 1.53576631 |
| 112 | Supraventricular arrhythmia (HP:0005115) | 1.50376886 |
| 113 | Ragged-red muscle fibers (HP:0003200) | 1.46916772 |
| 114 | Left ventricular hypertrophy (HP:0001712) | 1.46235217 |
| 115 | Oligomenorrhea (HP:0000876) | 1.42584903 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 8.31352022 |
| 2 | TTN | 6.35141893 |
| 3 | PIK3CG | 4.17932234 |
| 4 | PHKG2 | 4.08944138 |
| 5 | PHKG1 | 4.08944138 |
| 6 | NME1 | 3.45932833 |
| 7 | MYLK | 3.03114580 |
| 8 | DMPK | 2.59057732 |
| 9 | MAP2K3 | 2.35598708 |
| 10 | MUSK | 2.18189559 |
| 11 | PIK3CA | 2.05716179 |
| 12 | TRIB3 | 1.86622497 |
| 13 | NEK1 | 1.82973785 |
| 14 | ZAK | 1.71613196 |
| 15 | STK24 | 1.71015455 |
| 16 | PDK3 | 1.68987029 |
| 17 | PDK4 | 1.68987029 |
| 18 | PINK1 | 1.67089754 |
| 19 | MAP3K7 | 1.65100232 |
| 20 | MAP3K3 | 1.43005044 |
| 21 | MARK1 | 1.35661866 |
| 22 | STK38L | 1.34206168 |
| 23 | PDK2 | 1.32491978 |
| 24 | MAPK12 | 1.30113404 |
| 25 | LMTK2 | 1.18035996 |
| 26 | MAPKAPK3 | 1.14951281 |
| 27 | BCKDK | 1.12907720 |
| 28 | ILK | 1.11907981 |
| 29 | LIMK1 | 1.03087520 |
| 30 | CCNB1 | 0.97861855 |
| 31 | MAP2K4 | 0.94021020 |
| 32 | TRPM7 | 0.91384795 |
| 33 | MAP2K6 | 0.89509037 |
| 34 | LATS1 | 0.89336869 |
| 35 | EPHB2 | 0.84416378 |
| 36 | ROCK1 | 0.84098081 |
| 37 | NEK9 | 0.83918387 |
| 38 | ERBB3 | 0.82692360 |
| 39 | RIPK1 | 0.81022279 |
| 40 | PAK2 | 0.78081798 |
| 41 | CAMK2G | 0.75113855 |
| 42 | EPHB1 | 0.72997251 |
| 43 | AKT2 | 0.68712494 |
| 44 | MAP2K1 | 0.66927342 |
| 45 | TIE1 | 0.66277556 |
| 46 | CAMK4 | 0.63739703 |
| 47 | PRKAA2 | 0.63084358 |
| 48 | PRKAA1 | 0.62702904 |
| 49 | CAMK1 | 0.58018057 |
| 50 | DYRK1B | 0.54748448 |
| 51 | MOS | 0.53037931 |
| 52 | CAMK2A | 0.52966166 |
| 53 | PTK6 | 0.51552028 |
| 54 | NUAK1 | 0.51396826 |
| 55 | PDGFRA | 0.50792275 |
| 56 | FER | 0.49994610 |
| 57 | STK3 | 0.48249833 |
| 58 | MAPK15 | 0.48145405 |
| 59 | SGK2 | 0.47852636 |
| 60 | LATS2 | 0.47597039 |
| 61 | MST1R | 0.46161189 |
| 62 | CAMK2B | 0.45957200 |
| 63 | SGK3 | 0.43196466 |
| 64 | TAOK2 | 0.41628768 |
| 65 | PKN2 | 0.39542641 |
| 66 | SIK1 | 0.38963856 |
| 67 | CDC42BPA | 0.38962649 |
| 68 | MAPK13 | 0.37895669 |
| 69 | NLK | 0.36219515 |
| 70 | PRKG1 | 0.36080466 |
| 71 | ROCK2 | 0.35550965 |
| 72 | MAP3K13 | 0.35200233 |
| 73 | TGFBR2 | 0.33156120 |
| 74 | RPS6KB2 | 0.32679750 |
| 75 | PRKACB | 0.32550495 |
| 76 | DDR2 | 0.32198065 |
| 77 | INSRR | 0.30788474 |
| 78 | PTK2B | 0.29460923 |
| 79 | MAP3K5 | 0.28249251 |
| 80 | SGK223 | 0.28215657 |
| 81 | SGK494 | 0.28215657 |
| 82 | PNCK | 0.28035002 |
| 83 | CAMK2D | 0.25867377 |
| 84 | ERN1 | 0.25197239 |
| 85 | RPS6KA2 | 0.24999718 |
| 86 | PAK4 | 0.24478359 |
| 87 | MAPK7 | 0.23749513 |
| 88 | MAP3K10 | 0.23565466 |
| 89 | PAK3 | 0.22628445 |
| 90 | MARK2 | 0.21042874 |
| 91 | PRKD1 | 0.20837472 |
| 92 | MAPK11 | 0.20398397 |
| 93 | FGFR1 | 0.20363351 |
| 94 | LRRK2 | 0.20317393 |
| 95 | DAPK3 | 0.19797784 |
| 96 | MAPK10 | 0.19081849 |
| 97 | STK11 | 0.19071038 |
| 98 | RPS6KB1 | 0.18638356 |
| 99 | PRKACG | 0.18092728 |
| 100 | TNIK | 0.18044586 |
| 101 | PRKACA | 0.17586905 |
| 102 | BMPR1B | 0.17339103 |
| 103 | SGK1 | 0.16910649 |
| 104 | FRK | 0.16441368 |
| 105 | MTOR | 0.16324022 |
| 106 | ICK | 0.16290108 |
| 107 | MAPK4 | 0.15839384 |
| 108 | MAP3K6 | 0.15245693 |
| 109 | RPS6KA6 | 0.15193642 |
| 110 | GSK3A | 0.15183344 |
| 111 | PKN1 | 0.14599401 |
| 112 | DAPK2 | 0.14287388 |
| 113 | RPS6KA3 | 0.13971489 |
| 114 | MAPKAPK2 | 0.13648369 |
| 115 | GRK7 | 0.13481696 |
| 116 | TESK1 | 0.11342867 |
| 117 | MAP4K2 | 0.10459864 |
| 118 | RPS6KA1 | 0.08779454 |
| 119 | MARK3 | 0.08346117 |
| 120 | PAK1 | 0.07802525 |
| 121 | TAOK1 | 0.07724257 |
| 122 | KSR2 | 0.07680706 |
| 123 | MAP3K11 | 0.07642265 |
| 124 | MAPKAPK5 | 0.07626336 |
| 125 | EPHA3 | 0.07507870 |
| 126 | CDK8 | 0.07382987 |
| 127 | MET | 0.06804938 |
| 128 | TGFBR1 | 0.06666027 |
| 129 | EEF2K | 0.06614131 |
| 130 | FGFR3 | 0.06296430 |
| 131 | PAK6 | 0.06244283 |
| 132 | WNK1 | 0.06012714 |
| 133 | RPS6KC1 | 0.05490053 |
| 134 | RPS6KL1 | 0.05490053 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 5.24216090 |
| 2 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 4.44233218 |
| 3 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 4.37958736 |
| 4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.94688478 |
| 5 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.92198363 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.58694281 |
| 7 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.33722901 |
| 8 | Tight junction_Homo sapiens_hsa04530 | 2.06840318 |
| 9 | Circadian rhythm_Homo sapiens_hsa04710 | 2.04949017 |
| 10 | Focal adhesion_Homo sapiens_hsa04510 | 2.00392982 |
| 11 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.95382629 |
| 12 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.77995979 |
| 13 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.75811095 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.73530038 |
| 15 | Parkinsons disease_Homo sapiens_hsa05012 | 1.72468154 |
| 16 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.71908727 |
| 17 | Insulin resistance_Homo sapiens_hsa04931 | 1.71723098 |
| 18 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.68367739 |
| 19 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.62470865 |
| 20 | Carbon metabolism_Homo sapiens_hsa01200 | 1.56971135 |
| 21 | Galactose metabolism_Homo sapiens_hsa00052 | 1.55241513 |
| 22 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.55228778 |
| 23 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.52871583 |
| 24 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.52625277 |
| 25 | Viral myocarditis_Homo sapiens_hsa05416 | 1.51277451 |
| 26 | Alzheimers disease_Homo sapiens_hsa05010 | 1.49565716 |
| 27 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.46474741 |
| 28 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.46266971 |
| 29 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.45285773 |
| 30 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.42053250 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.38041783 |
| 32 | Adherens junction_Homo sapiens_hsa04520 | 1.27935179 |
| 33 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.26446510 |
| 34 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.23842110 |
| 35 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.22177934 |
| 36 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.17777655 |
| 37 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.17494896 |
| 38 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.12093053 |
| 39 | Amoebiasis_Homo sapiens_hsa05146 | 1.10811275 |
| 40 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.05452540 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.04126649 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.99678216 |
| 43 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.92771367 |
| 44 | Huntingtons disease_Homo sapiens_hsa05016 | 0.88887390 |
| 45 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.87996546 |
| 46 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.87018030 |
| 47 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.84669547 |
| 48 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.83116231 |
| 49 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.82895554 |
| 50 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.79509347 |
| 51 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.78425077 |
| 52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.77357767 |
| 53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.76997679 |
| 54 | Circadian entrainment_Homo sapiens_hsa04713 | 0.76075108 |
| 55 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.74826295 |
| 56 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.74725518 |
| 57 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.74291942 |
| 58 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.72964772 |
| 59 | Renin secretion_Homo sapiens_hsa04924 | 0.71618003 |
| 60 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.71610677 |
| 61 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.70257201 |
| 62 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.69344972 |
| 63 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.68449871 |
| 64 | Salivary secretion_Homo sapiens_hsa04970 | 0.67494131 |
| 65 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.65957909 |
| 66 | Platelet activation_Homo sapiens_hsa04611 | 0.64662314 |
| 67 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.61260488 |
| 68 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.60938469 |
| 69 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.60712857 |
| 70 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.59697331 |
| 71 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.58653857 |
| 72 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.57883621 |
| 73 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54589044 |
| 74 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50073822 |
| 75 | Long-term potentiation_Homo sapiens_hsa04720 | 0.49906738 |
| 76 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.49856916 |
| 77 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.49581990 |
| 78 | Bladder cancer_Homo sapiens_hsa05219 | 0.45622572 |
| 79 | Long-term depression_Homo sapiens_hsa04730 | 0.43922964 |
| 80 | Melanogenesis_Homo sapiens_hsa04916 | 0.43247034 |
| 81 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.42858056 |
| 82 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41944841 |
| 83 | Histidine metabolism_Homo sapiens_hsa00340 | 0.41699641 |
| 84 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.40509806 |
| 85 | Lysine degradation_Homo sapiens_hsa00310 | 0.40338994 |
| 86 | Peroxisome_Homo sapiens_hsa04146 | 0.39390061 |
| 87 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.36234934 |
| 88 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.36049932 |
| 89 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.35755126 |
| 90 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.34031999 |
| 91 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.32009679 |
| 92 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.31972835 |
| 93 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.29922227 |
| 94 | Olfactory transduction_Homo sapiens_hsa04740 | 0.29671602 |
| 95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.29599534 |
| 96 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.28305250 |
| 97 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.27813042 |
| 98 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.27752839 |
| 99 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.26996692 |
| 100 | Phototransduction_Homo sapiens_hsa04744 | 0.26395049 |
| 101 | Sulfur relay system_Homo sapiens_hsa04122 | 0.26391008 |
| 102 | Pathways in cancer_Homo sapiens_hsa05200 | 0.25789281 |
| 103 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.25469825 |
| 104 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.24994360 |
| 105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.24690391 |
| 106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.23961684 |
| 107 | Bile secretion_Homo sapiens_hsa04976 | 0.23497333 |
| 108 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.23181426 |
| 109 | Melanoma_Homo sapiens_hsa05218 | 0.22705111 |
| 110 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.22098184 |
| 111 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.20372056 |
| 112 | Insulin secretion_Homo sapiens_hsa04911 | 0.20355665 |
| 113 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.20169433 |
| 114 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.19628428 |
| 115 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.19269832 |
| 116 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.19024062 |
| 117 | Salmonella infection_Homo sapiens_hsa05132 | 0.18619814 |
| 118 | Malaria_Homo sapiens_hsa05144 | 0.18465461 |
| 119 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.18149223 |
| 120 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.17727956 |
| 121 | HTLV-I infection_Homo sapiens_hsa05166 | 0.17641079 |
| 122 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.17210854 |
| 123 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.17180312 |
| 124 | Gap junction_Homo sapiens_hsa04540 | 0.16383953 |
| 125 | ABC transporters_Homo sapiens_hsa02010 | 0.16170062 |
| 126 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.15623942 |
| 127 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.15491231 |
| 128 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.15212490 |
| 129 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.14891788 |
| 130 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.14754765 |
| 131 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.10200302 |
| 132 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.10068706 |
| 133 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.09086447 |

